Trial intelligence / Profile preview

Timing of midazolam before ketamine and post-anesthesia delirium in minor gynecologic surgery

IRCT2016010518091N7Phase 3Completed

Sponsor
Hormozgan University of Medical Sciences
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of midazolam and ketamine (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Delirium after awakening from anesthesia. Started Jan 2016; status: completed.

02

Drugs

midazolamketamine

Beyond the preview

Go deeper on IRCT2016010518091N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016010518091N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call